A new study has found that low doses of THC may reverse age-related cognitive decline by enhancing the formation of new neural connections. In particular, the activation of the mTOR pathway was found to improve energy and protein production in the brain. Further research and proper clinical trials are now needed to confirm the potential efficacy of THC as an anti-aging treatment.
A study published in ACS Pharmacology & Translation Science reveals how low doses of THC could play a significant role in reversing the cognitive decline commonly associated with aging, at least based on experiments conducted on mice.
For more news like this, along with all the latest in legalization, research, and lifestyle, download our free cannabis news app.
A study conducted by the University Hospital of Bonn in collaboration with the Hebrew University of Jerusalem explored the effects of administering small daily doses of THC to elderly mice. These 18-month-old mice, which are roughly equivalent to 65-year-old humans, received THC for 28 days through implanted pumps. This long-term treatment led to notable improvements in their learning, memory, and cognitive abilities.
Researchers observed a remarkable enhancement in the formation of new synaptic connections between neurons, a process typically associated with younger brains. The ability to form new neural connections is essential for maintaining cognitive functions, which generally decline with age.
Interestingly, these cognitive improvements were not replicated when the same treatment was applied to younger mice, suggesting that the anti-aging benefits of THC may be particularly effective in older subjects.
Researchers believe that THC works by activating a protein switch in the brain called mTOR (Mechanistic Target of Rapamycin). This activation boosts energy production and promotes the formation of synaptic proteins, which are crucial for maintaining cognitive functions such as memory and learning.
According to Dr. Andras Bilkei-Gorzo of the Institute of Molecular Psychiatry at the University Hospital of Bonn, long-term THC treatment first enhances cognition by increasing energy and protein production in the brain. This effect is followed by a reduction in mTOR activity, which helps slow age-related metabolic processes in other parts of the body, including adipose tissue. This dual action on mTOR and the body’s metabolic processes could form the basis of an effective anti-aging therapy.
“Our study suggests that a dual effect on mTOR activity and the metabolome could form the foundation of an effective anti-aging and cognition-enhancing medication,” Dr. Bilkei-Gorzo stated.
One of the most significant aspects of this research is the dual role THC plays in both the brain and the body. The mTOR pathway is essential for regulating cell growth, metabolism, and protein synthesis, and THC’s ability to activate this pathway has profound implications for cognitive health. By stimulating mTOR activity, the compound promotes brain energy and protein production, which are essential for the formation of new neural connections. These new connections, in turn, contribute to cognitive improvements in older subjects.
However, the impact of THC does not stop there. Over time, the treatment seems to reduce mTOR activity, particularly in peripheral tissues such as fat, helping to combat the metabolic effects of aging. By influencing both the central nervous system and peripheral metabolism, THC offers a holistic approach to mitigating the negative effects of aging on cognition.
Although this study was conducted on mice, emerging evidence suggests that THC may offer similar cognitive benefits to humans.
A separate study, published in 2024, examined the relationship between THC consumption and cognitive function in adults aged 45 and older. This research found that individuals who used THC recreationally were less likely to experience subjective cognitive decline (SCD) compared to those who did not use cannabis.
The cohort of 4,744 adults in the study showed a striking 96% reduction in the risk of SCD among those who had consumed THC compared to non-users. This link between THC and cognitive function suggests that the benefits of the compound may extend beyond animal models to human populations. While further clinical studies are necessary to fully understand how THC interacts with human aging processes, early results are promising.
Despite these encouraging findings, further studies are needed to explore how THC could be used as a therapeutic agent for age-related cognitive decline in humans. Clinical trials on older adults would be the next logical step to confirm the compound’s efficacy, determine appropriate dosages, and assess long-term effects. Additionally, researchers should investigate whether THC affects other aspects of aging, such as muscle mass, immune function, and overall metabolism.
—
(Featured image by CRYSTALWEED cannabis via Unsplash)
DISCLAIMER: This article was written by a third-party contributor and does not reflect the opinion of Hemp.im, its management, staff, or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the company may believe that its expectations are based on reasonable assumptions, the actual results that the company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in Newsweed, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
The Superior Court of Justice in Brazil has legalized the cultivation, processing, and sale of…
Poland has classified medical cannabis as a high-risk substance (Group I-N) alongside heroin and fentanyl.…
The Australian Senate has rejected the Legalising Cannabis Bill 2023, which proposed a national framework…
The Fijian government is drafting legislation after public consultations to establish a transparent, inclusive framework…
A Leafwell study found chronic pain as the top condition treated with medical cannabis, although…
A survey found that women comprise 61% of home cannabis growers, marking a diversion from…